Savient Files Chapter 11; Krystexxa to Remain Available - BioWorld O...

10/15/13

Savient Files Chapter 11; Krystexxa to Remain Available
BioWorld Online
Savient Pharmaceuticals Inc. said that it is committed to keeping Krystexxa on the market throughout and after its bankruptcy process. The struggling biotech filed Chapter 11 voluntarily in the Bankruptcy Court for the District of Delaware, along with ...